USTEKINUMAB
ustekinumab 90 mg/mL injection, 1 mL syringe
USTEKINUMAB (14917D)
14917D
Manner of administration:Injection
Restriction (Streamlined authority code: 16835)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Whole body
Restriction (Streamlined authority code: 16967)
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Face, hand, foot
